Mesenchymal Stem Cells may be a viable treatment option for Post Treatment Lyme Disease Syndrome (PTLDS). Stem cells have been proven to have strong anti-inflammatory properties. Through the use of large cell quantity transplants, the youthful stem cells have a regulatory nature on the body
Stem Cells therapy
European Clinical Trials Information Network
European Clinical Trials Information Network The European Clinical Trials Information Network revolutionizes how patients across Europe access clinical trial information. By eliminating language barriers, our platform ensures that everyone, regardless of their native language, can Read more…
